Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Risk of Thyroid Cancer Among Solid Organ Transplant Recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017

Same author

The impact of age and gender on papillary thyroid cancer survival.

The Journal of clinical endocrinology and metabolism·2012

Same author

Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study.

The Journal of clinical endocrinology and metabolism·2010

Same author

Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.

The Journal of clinical endocrinology and metabolism·2009

Same author

Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer.

The Journal of clinical endocrinology and metabolism·2009

Same author

Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.

The Journal of clinical endocrinology and metabolism·2005

Search research articles

Related Experiment Videos

Subclinical thyroid dysfunction in the elderly.

J J Jayme¹, P W Ladenson

¹Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD 21287-4904, USA.

Trends in Endocrinology and Metabolism: TEM

|March 1, 1994

Summary

This summary is machine-generated.

Subclinical thyroid dysfunction, including hypothyroidism and hyperthyroidism, is common in older adults. Treatment for subclinical hypothyroidism may be indicated by antibodies, symptoms, or high LDL-cholesterol.

Related Experiment Videos

Area of Science:

Endocrinology
Geriatrics
Internal Medicine

Background:

Subclinical thyroid dysfunction, characterized by abnormal thyroid-stimulating hormone (TSH) levels with normal free thyroxine, is prevalent in the elderly.
Subclinical hypothyroidism affects about 10% of women and 3% of men over 65, often due to autoimmune thyroiditis or prior hyperthyroidism treatment.
Subclinical hyperthyroidism occurs in 1%-2% of older individuals, frequently caused by over-replacement of thyroid hormone therapy or mild endogenous hyperthyroidism.

Purpose of the Study:

To summarize the prevalence, causes, and management indications for subclinical thyroid dysfunction in older populations.
To highlight the risks associated with subclinical hyperthyroidism in the elderly, such as atrial fibrillation and osteoporosis.

Main Methods:

Review of existing literature on subclinical thyroid dysfunction in individuals over 65 years old.
Analysis of diagnostic criteria based on serum TSH and free thyroxine levels.
Identification of clinical factors and laboratory findings for differentiating causes and guiding treatment.

Main Results:

Subclinical hypothyroidism indications for L-thyroxine therapy include antithyroid antibodies, deficiency symptoms, and elevated LDL-cholesterol.
Subclinical hyperthyroidism is primarily caused by excessive thyroid hormone therapy, Graves' disease, or nodular goiter.
Elderly patients with subclinical hyperthyroidism face increased risks of atrial fibrillation and osteoporosis.

Conclusions:

Subclinical thyroid dysfunction requires careful evaluation in older adults due to potential health consequences.
Management strategies for subclinical hypothyroidism should consider risk factors and symptoms.
Recognizing and managing subclinical hyperthyroidism is crucial to prevent serious complications in the elderly.